XNAS

Datos históricos de LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock · LBRX

$37.22

▲ +0.03 (+0.08%)

Última operación · 10/10/2026, 18:34:24 UTC

Variación en el periodo
+141.06%
Máximo
US$50.16
25 de agosto de 2026
Mínimo
US$14.32
11 de noviembre de 2025
Volumen medio diario
0.28 M

Del 10 de octubre de 2025 al 9 de octubre de 2026. Precios en dólares, ajustados por splits.

FechaAperturaMáximoMínimoCierreVar.Volumen
9 oct 202635.0138.5035.0137.22+7.54%642,582.564
8 oct 202633.8335.7333.1334.61+1.32%440,665.999
7 oct 202634.0236.5734.0034.16−0.29%385,034.094
6 oct 202635.2535.5933.7334.26−1.04%432,766.123
5 oct 202636.4136.8834.4734.62−6.41%494,494.865
2 oct 202637.7238.8236.7536.99−0.78%388,885.545
1 oct 202638.1038.5937.1337.28−2.87%278,891.736
30 sep 202637.6139.2337.3438.38+2.95%437,215.947
29 sep 202637.8938.1336.9837.28−1.61%713,379.551
28 sep 202637.2438.1736.5737.89+1.50%534,587.936
25 sep 202637.8538.5736.9937.33−1.24%398,942.204
24 sep 202639.1339.3937.5637.80−3.55%413,501.637
23 sep 202642.8042.8038.8439.19−8.20%481,680.722
22 sep 202643.4043.4041.2142.69−0.70%244,401.973
21 sep 202642.5543.2241.5442.99+1.22%310,155.277
18 sep 202642.2242.5441.3942.47+0.78%531,641.696
17 sep 202643.3343.5041.7842.14−1.01%314,496.626
16 sep 202643.3743.9442.1742.57−1.09%231,919.673
15 sep 202644.8444.8442.5043.04−4.01%320,546.548
14 sep 202644.9545.7244.5544.84+0.47%242,778.78
11 sep 202646.8047.6844.4044.63−3.50%208,383.227
10 sep 202647.2047.2045.5046.25−2.98%174,791.922
9 sep 202649.0749.8147.4647.67−3.48%190,142.19
8 sep 202648.5349.6247.1549.39+0.10%300,998.028
4 sep 202647.4749.9147.4749.34+3.83%205,964.414
3 sep 202648.8848.9146.7247.52−3.96%282,475.155
2 sep 202647.3149.9346.4449.48+5.05%518,387.346
1 sep 202647.2148.2146.9247.10−0.34%201,986.599
31 ago 202647.4747.5046.3847.26−0.98%386,950.953
28 ago 202647.6449.2546.3747.73−0.33%230,559.034

Cotizaciones en tiempo real durante el horario de mercado. Fuentes: Massive y Financial Modeling Prep. Esta página tiene fines informativos y no constituye asesoría financiera.